Which is better, AGX or MYCR.ST?

On the Buffett-Fit framework, Mycronic AB (publ) (MYCR.ST) currently grades higher than AGX — 77/100 (B grade) vs 56/100 (C). That said, "better" depends on which framework you trust — AGX wins on Joel Greenblatt; MYCR.ST wins on Warren Buffett, Benjamin Graham, Philip Fisher, Peter Lynch, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy AGX or MYCR.ST?

This page is an educational comparison, not investment advice. Both AGX and MYCR.ST are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is AGX better than MYCR.ST for value investing?

On the Buffett-style value-investing framework, MYCR.ST currently grades higher — 77/100 vs 56/100, a 21-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between AGX and MYCR.ST on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). AGX currently scores 56/100 (C grade); MYCR.ST scores 77/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, AGX or MYCR.ST?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. AGX and MYCR.ST are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, AGX or MYCR.ST?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are AGX and MYCR.ST both Industrials stocks?

Yes — both Argan, Inc. (AGX) and Mycronic AB (publ) (MYCR.ST) operate in the Industrials sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this AGX vs MYCR.ST comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Argan

AGX$8.13BIndustrials Market cap, Sector

Mycronic AB (publ)

MYCR.ST$61.28BIndustrials Market cap, Sector

Overall winner

Mycronic AB (publ)

AGX 16 MYCR.ST

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

AGX1wins

6winsMYCR.ST

Warren Buffett

56D

B77

Benjamin Graham

78B

A85

Philip Fisher

69C

A85

Peter Lynch

67C

C69

Joel Greenblatt

68C

C66

Charlie Munger

59D

B78

Terry Smith

65C

B77

Side-by-side metrics

Metric	AGX	MYCR.ST
Market cap	$8.13B	$61.28B Winner
P/E (TTM)	60.1x	37.5x Winner
EV/EBIT	69.7x	29.1x Winner
ROIC (TTM)

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

AGX leads on

Debt / Equity-vs 0.0x+100%
EPS CAGR 5y42.43%vs 28.15%+34%
ROIC (TTM)27.61%vs 20.79%+25%
Revenue CAGR 5y16.7%vs 15.75%+6%

MYCR.ST leads on

More like AGX

AGX vs 6532.T AGX vs SALIK.AE AGX vs GPP.WA AGX vs RAA.DE

More like MYCR.ST

MYCR.ST vs 6532.T MYCR.ST vs SALIK.AE

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Industries

Rankings

Glossary

Tools & Methodology

Argan

Mycronic AB (publ)

Fit scores by strategy

Side-by-side metrics

Where each one wins

More like AGX

More like MYCR.ST

Related on invest-like

Key terms in this analysis